https://invest-in-myself.com/2024/02/23/thinking-beyond-big-tech/
What's happening is that these companies are maturing. They are more predictable and closer to the consensus, aligning closer within parity to the general market. The Magnificent 7 is no longer a group of companies that produces alpha; it is a risk management group. The days of these names creating outsized gains in your portfolio are likely over. These companies will succumb to the law of large numbers, ev...
What's happening is that these companies are maturing. They are more predictable and closer to the consensus, aligning closer within parity to the general market. The Magnificent 7 is no longer a group of companies that produces alpha; it is a risk management group. The days of these names creating outsized gains in your portfolio are likely over. These companies will succumb to the law of large numbers, ev...
https://invest-in-myself.com/2024/02/13/moderna-ai-leader-in-medicine/
Cancer and Herpes are only two potential growth catalysts for Moderna. The company has a long runway for growth, with over 45 developing drugs and 38 ongoing clinical trials. There's a buffet selection of diseases, even though most of these trials will fail. Getting 10-15 drugs approved in the next five years could give Moderna a higher market cap than any other biotech company.
Cancer and Herpes are only two potential growth catalysts for Moderna. The company has a long runway for growth, with over 45 developing drugs and 38 ongoing clinical trials. There's a buffet selection of diseases, even though most of these trials will fail. Getting 10-15 drugs approved in the next five years could give Moderna a higher market cap than any other biotech company.
1
Myth #1: Quants, sophisticated algorithms, and the brightest minds in the world struggle to beat the market, and most do not. The odds are that Sam from Nebraska will not outperform the market and is better off not playing around with individual stocks. Just invest in index funds.
Debunking Investing Myths
Debunking Investing Myths
mRNAの科学がよく知られるようになったので、RNAワクチン革命が起こると思いますか?
既に起こっています。現在、RNA治療薬やワクチンを使用した臨床試験が約250件行われています。5年前は1件しかなかった可能性があります。従って、これらはありとあらゆる感染症に対して適用され、淋病、インフルエンザ、出血熱のワクチン、HIVなどです。...これら全てはCOVIDから生まれました。
「COVID-19ワクチンの開発に至る研究に貢献した科学者の一人であり、2023年のノーベル医学賞受賞者であるドリュー・ワイスマン」という名前があります。
既に起こっています。現在、RNA治療薬やワクチンを使用した臨床試験が約250件行われています。5年前は1件しかなかった可能性があります。従って、これらはありとあらゆる感染症に対して適用され、淋病、インフルエンザ、出血熱のワクチン、HIVなどです。...これら全てはCOVIDから生まれました。
「COVID-19ワクチンの開発に至る研究に貢献した科学者の一人であり、2023年のノーベル医学賞受賞者であるドリュー・ワイスマン」という名前があります。
翻訳済み